Drug Trial Radar · NCT03436615
A Study to Evaluate the Safety and Efficacy of SB206 in Subjects With Molluscum Contagiosum
Last checked: Nov 19, 2026Latest source record: May 6, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
256
Actual
Start
Jan 24, 2018
Primary completion
Nov 3, 2018
Study completion Nov 3, 2018
Sponsor
- Lead sponsor
- Novan, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Premier Research
- First posted
- Feb 19, 2018
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Sequential
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a phase 2 multi-center, randomized, double-blind, vehicle-controlled ascending dose study to be conducted in non-immunocompromised subjects with molluscum contagiosum.
Conditions
- Molluscum Contagiosum
Interventions
SB206 4%Drug
Twice daily
SB206 8%Drug
Twice daily
SB206 12%Drug
Once or twice daily
PlaceboDrug
Once or twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of Subjects Achieving Complete Clearance at Week 12Time frame: 12 weeks
Locations
18 sites in 1 country. Site status is shown where the registry gives one.
Premier Site# 266
Scottsdale, Arizona
Premier Site# 260
Santa Ana, California
Premier Site# 257
Thornton, Colorado
Premier Site# 264
Doral, Florida
Premier Site# 116
Newnan, Georgia
Premier Site# 251
Indianapolis, Indiana
Premier Site# 253
Lenexa, Kansas
Premier Site# 117
Louisville, Kentucky
Premier Site# 182
Las Vegas, Nevada
Premier Site# 252
Norman, Oklahoma
Premier Site# 237
Gresham, Oregon
Premier Site# 259
Charleston, South Carolina
Premier Site# 255
Mt. Pleasant, South Carolina
Premier Site# 131
Houston, Texas
Premier Site# 167
Houston, Texas
Premier Site# 224
San Antonio, Texas
Premier Site# 256
Salt Lake City, Utah
Premier Site# 267
Richmond, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.